1. Design and Analysis of Bioavailability and Bioequivalence Studies
2. Huque, M.F. Dubey, S.; Fredd, S. Establishing Therapeutic Equivalence with Clinical Endpoints.In The 1989 Proceedings of the Biopharmaceutical Section of the American Statistician Association1989, 46–52 Alexandria, VA, U.S.A.
3. Huque, M.F. Dubey, S. Design and Analysis of Therapeutic Equivalence Clinical with a Binary Clinical Endpoint.In The 1990 Proceedings of the Biopharmaceutical Section of the American Statistician Association1990, 46–52 Alexandria, VA, U.S.A.
4. Significance Testing to Establish Equivalence between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables
5. Makuch, R.W. Johnson, M. Active Control equivalence Studies: Planning and Interpretation. InStatistical Issues in Drug Research and Development; Peace, K. E.; Ed. Marcel Dekker, Inc. New York, 1990, 238–246.